[KongchangAI]
Unverified50% confidenceDecision RuleTime unknown

选择第二代抗组胺药(西替利嗪、氯雷他定、地氯雷他定、非索非那定)而非第一代(氯苯那敏、苯海拉明),第二代24小时药效且极少透过血脑屏障,嗜睡副作用发生率<10%

0
Sources
50%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/211370
API
curl https://kongchang.com/api/v1/knowledge/claims/211370
MCP
get_claim(id=211370)